Predicting kit for survival of lung cancer patients and the method of providing the information for predicting survival of lung cancer patients

• 1. 用于预测肺癌患者生存期的生物标志物及相关产品 [P] . 中国专利： CN113373232A . 2021-09-10
• 2. 晚期乳腺癌生存概率预测列线图、生存概率预测方法及患者分类方法 [P] . 中国专利： CN111354462A . 2020-06-30
• 3. Predicting kit for survival of lung cancer patients and the method of providing the information for predicting survival of lung cancer patients [P] . 韩国专利： KR101864331B1 . 2018-06-04

  机译： 肺癌患者生存预测试剂盒和提供信息以预测肺癌患者生存的方法

• 4. Predicting kit for survival of lung cancer patients and the method of providing the information for predicting survival of lung cancer patients [P] . 韩国专利： KR20170010331A . 2017-01-26

  机译： 肺癌患者生存预测试剂盒和提供信息以预测肺癌患者生存的方法

• 5. Predicting kit for survival of lung cancer patients and the method of providing the information for predicting survival of lung cancer patients [P] . 韩国专利： KR20170018538A . 2017-02-20

  机译： 肺癌患者生存预测试剂盒和提供信息以预测肺癌患者生存的方法

• 1. A radiomics prognostic scoring system for predicting progression-free survival in patients with stage Ⅳ non-small cell lung cancer treated with platinum-based chemotherapy [J] . Lan He, Zhenhui Li, Xin Chen, 中国癌症研究（英文版） . 2021,第005期
• 2. Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients [J] . Guo-Wen Lin, Guo-Hai Shi, Xiao-Jian Qin, 亚洲男性学杂志（英文版） . 2009,第004期
• 3. Prostate-specific antigen half-life： a new predictor of progression- free survival and overall survival in Chinese prostate cancer patients [J] . Guo-Wen Lin, Xu-Dong Yao, Shi-Lin Zhang, 亚洲男性学杂志：英文版 . 2009,第004期
• 4. Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validation. [J] . Baktiar Hasan, Laurent Greillier, Athanasios Pallis, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第16期
• 5. Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a “PET biopsy” method [J] . Yizhao Xie, Bingxin Gu, Xichun Hu, Cancer Management and Research . 2019,第2期
• 6. lncRNA CCHE1 increased proliferation, metastasis and invasion of non-small lung cancer cells and predicted poor survival in non-small lung cancer patients [J] . Y. Liao, S. Cheng, J. Xiang, European review for medical and pharmacological sciences. . 2018,第6期
• 7. Gene expression profiles predict survival of patients with advanced non-small cell lung cancers [C] . Harun Roslan, Hadi Jalal, Mhazir Nur Shukriyah, 2011 Fourth International Conference on Modeling, Simulation and Applied Optimization . 2011
• 8. The role of smoking status on postoperative complications and survival in lung cancer patients presenting to M.D. Anderson Cancer Center [D] . Merriman, Kelly Willis. 2007
• 9. Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a PET biopsy method [O] . Yizhao Xie, Bingxin Gu, Xichun Hu, 2019
• 10. Comparison of generic and lung cancer-specific quality of life instruments for predictive ability of survival in patients with advanced lung cancer [O] . 2016

• 1. Prognostic nomograms for predicting overall survival and causespecific survival of signet ring cell carcinoma in colorectal cancer patients [J] . Fu-Rong Kou ,Yang-Zi Zhang ,Wei-Ran Xu . 世界临床病例杂志 . 2021,第011期
• 2. The Correlation of Lung Function Indexes and Survival Time of Patients with Advanced Lung Cancer [J] . Wenjing Xu ,Zhenghua Jiang ,Dongyun Huang . 癌症治疗（英文） . 2013,第1期
• 3. EGFR突变状态对Ⅲ期非鳞非小细胞肺癌患者放化疗近期疗效和长期生存的预测价值 [C] . 李付海 ,白桦 ,李夏南 . 中国抗癌学会肺癌专业委员会第十二届全国肺癌学术大会 . 2011
• 4. RNSCLC--PRSP软件预测可切除T1-3N0-2M0非小细胞肺癌患者预后风险及生存 [A] . 张云魁 . 2020